Abuqayyas L - Search Results

1

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE Jr, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY. Almagro JC, et al. Among authors: abuqayyas l. MAbs. 2014 May-Jun;6(3):577-618. doi: 10.4161/mabs.28421. Epub 2014 Mar 3. MAbs. 2014. PMID: 24589717 Free PMC article.

2

Assessments of antibody biodistribution.

Glassman PM, Abuqayyas L, Balthasar JP. Glassman PM, et al. Among authors: abuqayyas l. J Clin Pharmacol. 2015 Mar;55 Suppl 3:S29-38. doi: 10.1002/jcph.365. J Clin Pharmacol. 2015. PMID: 25707961 Review.

3

High-throughput method development for sensitive, accurate, and reproducible quantification of therapeutic monoclonal antibodies in tissues using orthogonal array optimization and nano liquid chromatography/selected reaction monitoring mass spectrometry.

Duan X, Abuqayyas L, Dai L, Balthasar JP, Qu J. Duan X, et al. Among authors: abuqayyas l. Anal Chem. 2012 May 15;84(10):4373-82. doi: 10.1021/ac2034166. Epub 2012 Apr 27. Anal Chem. 2012. PMID: 22519810 Free PMC article.

4

Pharmacokinetic mAb-mAb interaction: anti-VEGF mAb decreases the distribution of anti-CEA mAb into colorectal tumor xenografts.

Abuqayyas L, Balthasar JP. Abuqayyas L, et al. AAPS J. 2012 Sep;14(3):445-55. doi: 10.1208/s12248-012-9357-2. Epub 2012 Apr 18. AAPS J. 2012. PMID: 22528507 Free PMC article.

5

Investigation of the role of FcγR and FcRn in mAb distribution to the brain.

Abuqayyas L, Balthasar JP. Abuqayyas L, et al. Mol Pharm. 2013 May 6;10(5):1505-13. doi: 10.1021/mp300214k. Epub 2012 Aug 23. Mol Pharm. 2013. PMID: 22838637

6

Application of knockout mouse models to investigate the influence of FcγR on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibody.

Abuqayyas L, Balthasar JP. Abuqayyas L, et al. Int J Pharm. 2012 Dec 15;439(1-2):8-16. doi: 10.1016/j.ijpharm.2012.09.042. Epub 2012 Sep 24. Int J Pharm. 2012. PMID: 23018115

7

Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer.

Abuqayyas L, Balthasar JP. Abuqayyas L, et al. J Pharmacokinet Pharmacodyn. 2012 Dec;39(6):683-710. doi: 10.1007/s10928-012-9279-8. Epub 2012 Nov 27. J Pharmacokinet Pharmacodyn. 2012. PMID: 23184417 Free PMC article.

8

Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody.

Abuqayyas L, Zhang X, Balthasar JP. Abuqayyas L, et al. Int J Pharm. 2013 Feb 28;444(1-2):185-92. doi: 10.1016/j.ijpharm.2013.01.001. Epub 2013 Jan 28. Int J Pharm. 2013. PMID: 23370434 Free PMC article.

9

Evaluation of near infrared fluorescent labeling of monoclonal antibodies as a tool for tissue distribution.

Conner KP, Rock BM, Kwon GK, Balthasar JP, Abuqayyas L, Wienkers LC, Rock DA. Conner KP, et al. Among authors: abuqayyas l. Drug Metab Dispos. 2014 Nov;42(11):1906-13. doi: 10.1124/dmd.114.060319. Epub 2014 Sep 10. Drug Metab Dispos. 2014. PMID: 25209366 Free PMC article.

10

Development and Evaluation of Competitive Inhibitors of Trastuzumab-HER2 Binding to Bypass the Binding-Site Barrier.

Bordeau BM, Abuqayyas L, Nguyen TD, Chen P, Balthasar JP. Bordeau BM, et al. Among authors: abuqayyas l. Front Pharmacol. 2022 Feb 18;13:837744. doi: 10.3389/fphar.2022.837744. eCollection 2022. Front Pharmacol. 2022. PMID: 35250584 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page